Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

970.00p
   
  • Change Today:
    -45.00p
  • 52 Week High: 1,545.00p
  • 52 Week Low: 130.00p
  • Currency: UK Pounds
  • Shares Issued: 6.43m
  • Volume: 61,862
  • Market Cap: £62.33m
  • RiskGrade: 340
  • Beta: 0.01

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Alexis M. Sandler 187,727 £1,820,952
Vladislav Sandler Ph.D. 103,862 £1,007,461
Peter Redmond 13,991 £135,713

Major Shareholders

Notifier** Holding Value*
David John Smith 416,530 £4,040,341
Alexis Sandler 187,726 £1,820,942
Dr Vladislav Sandler 103,862 £1,007,461
Optiva Securities Limited 70,329 £682,191
Flascherberg Capital Anstalt 69,991 £678,913
Craig Auringer 59,593 £578,052
HSBC Client Holdings Nominee (UK) Limited 45,160 £438,052
Ron Valk 42,828 £415,432
Samantha Bauer 42,706 £414,248
Plum Capital 29,232 £283,550
43 North LLC 28,429 £275,761
Abdelatif LACHAB 6,500 £63,050
Wayne Gibson 6,500 £63,050

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 970.00p
Change Today -45.00p
% Change -4.43 %
52 Week High 1,545.00p
52 Week Low 130.00p
Volume 61,862
Shares Issued 6.43m
Market Cap £62.33m
Beta 0.01
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47% below the market average47% below the market average47% below the market average47% below the market average47% below the market average
56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average56.1% below the sector average
Price Trend
91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average91.8% below the market average
90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average90.91% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 03-Mar-2026

Time Volume / Share Price
11:16 2 @ 928.00p
17:07 150 @ 970.00p
16:35 837 @ 970.00p
16:35 1 @ 970.00p
16:35 199 @ 970.00p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page